Skip to main content
Latest news
Browse specialties
Breast cancer Genitourinary cancers Lung & thoracic cancers
In focus
Next-generation sequencing: Emerging biomarkers in thyroid and NSCLCs ctDNA and bladder cancer: Current understanding and beyond ROS1 fusion-positive NSCLC NSCLC driver mutations: Discussing the importance of RET, ALK and ROS1 alterations in NSCLC Early-stage NSCLC management: Surgery, targeted treatment and immunotherapy ALK fusion-positive NSCLC: International approaches to management RET fusion-positive NSCLC: Informing on the use of pralsetinib for patients with RET fusion-positive, advanced NSCLC COVID-19 & cancer
Conferences
SABCS 2022 ESMO 2022 2022 ASCO Annual Meeting
About us
Medicine Matters Oncology
EXTENDED SEARCH

01-02-2017 | Image

Figure 2: Copy-number variations in multiple myeloma.

a | Data provided are the average frequencies of recurrent chromosomal gain and loss reported in two studies in which single-nucleotide polymorphism (SNP) arrays were used to analyse samples from 114 (Ref. 55) and 192 (Ref. 76) patients with multiple myeloma. b | Frequency of focal changes in multiple myeloma. Data were obtained from a study using the GISTIC algorithm89 to analyse samples from 153 patients6. CNVs, copy-number variations.

print
PRINT
Image Credits